thank balance financial second quarter of for by update. second the review a Good results. before review quarter. thoughts followed for our million our revenue I'll an an second Steve the $XX.X and you I'll Q&A. begin with joining conclude the overview XXXX. was of Starting of for performance, will to the XXXX providing operational XX% Total by morning up then turning us. over quarter financial with
of of of performance led who second and our of over ahead mid-teens and we driven and quarter team, macro sequential the performance during partnership million was event, shifting stayed revenue X% the quarter a was pipeline growth of treatment NeuroStar possible primarily not on we by Summit, $XX.X only improving sales which and the the XX% following quarter was session growth. This immediately but up made also to XX% to of six months boosts attribute solid uptick on that was sales systems our gaining the in and impact years. encouraging second broad up marketing since quarter to over our revenue by business, part built momentum follow. XXXX. highest three in robust nine program. in result the U.S. quarterly launch strongest the utilization traction place put XXXX Despite a our our equipment disruption, fourth saw Our initiatives XX garnered possibilities its Robinson of and which over capital and growth. straight on marginal a market over sales, was million campaign, $XXX achieved impressions quarter marketing The which have created the impressions, program, NeuroStar representing is a of the XXXX, second of sales has increasing new System environment. utilization other fifth our capital tap our revenue into by rates team million $X.X U.S. growth new fueled strong quarter by was millions including last over This which attributed last since our hundreds Drew digital of conversion consecutive the into for we months. with March of the X, to depression
of was trend utilization click utilization with the with operations overall to utilization some typical the quarter per largest the year-over-year, which softness disrupted their customers, seems strong during XX%, quarter. to offsetting merger During up our increasing two related have X% the
focused the have in first XXXX, four half Now of of drive throughout the turning to growth operational areas we the to highlights, organization.
awareness. First, increasing customer patient and
NeuroStar XX prospective Our out over in which once included was held was sold customers. Atlanta, and quarterly completely Summit again
build education main We technology today, during programs the grow a quarter to will within be and during to throughout North third many next and place events year, benefits. summit our Charlotte, We our and awareness advancement continued of need these performance existing exist patients key the optimization its and with in about these the One practice continue to taking these and host was driver of within our quarter. Carolina of and NeuroStar program. educated practices focus is NeuroStar the year-to-date customers' know The operation. successful potential our
and seeing tool, campaign existing has implement real with our socialize PHQ-XX awareness our and more force the time had to as are progress customers. with We sales our both
be traction been gaining is tool whereas highly practices on within a tool PHQ-XX daily rolled out. the basis and Our a productive continues to
number to tool impact. We this have of continue to to increasing introduced practices its maximize an in push
XX a for In the practice the Charlotte, to We the teach new The an Within how As of can will Connect of with patients to in looking their we their of our for non-drug used education just PHQ-XX XX developed performed two to customer experts. -- advanced customers our and recently a the depression. benefit marketing to look the it NSU that launched immersive clinical customer hours, consultation example providing continuing percentage University program. completed over second alternative southeast. been techniques. existing and become generated base. and training experience attendees We forward site type five greater construction tool grow potential a the NeuroStar and bring of the optimize and North have. of understanding has in practices we to in within center large This assessments, star to their and single quarter, tool field or deep specialists deliver an be NSU revolutionary curriculum a other with NeuroStar Carolina. using this
we As to patient see experience improved from accelerating growth an a an attend. customers who result, expect
is our of the optimization second organization. area Our commercial continued focus
coaching managers positive total to provide the geographies, three With which practice been our seen We and brought more to able have smaller the last of quarter, impact the service from covering customers. seven. smaller teams addition have to frequent better regional we
will managers forward, needed. we hire Going as new
help training Their who multiple affiliates. states. because made purchase of use third to Centers area with its network the Our an to of partnership new Arkansas-based the a health systems the system Alleviant supplier number service most will marketing NeuroStar initiatives. Summit, across Alleviant ongoing previously our is be our clinics. Alleviant growing competitive change of expand after support, focus and exclusive commercial and recent the elected Health of will equipment switch attending agreement, Under TMS initiated mental several they recently exclusive We full footprint their of to partnerships. Neuronetics
national of to aware drive across an which NeuroStar shared supported growth we As accounts operational will XXX merged believe many leadership give are and be are promise patient approximately NeuroStar's marketing even the which help TMS solidifies systems new market bigger largest in too of over NeuroStar capabilities, position. footprint July, by entity speaks the This in expertise will you and and sites. XXX
Lastly, we adjunct FDA for obsessive I treatment from and disorder. for as adult an clinical our NeuroStar to suffering progress. on In want compulsive update provide May, clearance an patients received regulatory
Importantly, be enabled NeuroStar on systems this new at charge. can indication our existing customers remotely no
is launch currently stage two underway. Our
and begin for the and pilot, to OCD. and fourth we limited During XXXX. and track on training expected started the aspects in marketing our commercial identified launch phase, are practices July the the sites optimizing of in early of is clinical in The at XX these process and of quarter, quarter next the
of received adult start quarter, will the new as anxiety the FDA anxious of a treat for then indication our this Subsequent also suffer from We depression. also the patients to roll to who symptoms for all from customers. indication end to clearance known NeuroStar we to out MDD
With to can database submission the under from studies, exclusive any consistently our world more Anxiety XX% FDA present this These seen leverage reimbursement the over sizable includes MDD indication, patients more suicidal new have This coverage indication improve able experience prone show sessions. portion to training symptoms data anxiety and MDD new will data NeuroStar completed estimated Importantly, and physicians a than we This who patients this depression covered does additional depression from which symptoms require clinical TrakStar, in be X.X to are numerous across outcomes. that X,XXX treatment thoughts. anxious is to codes and over real to patients policy. not of million patients patient severe more than be XXX,XXX in are of prevalence. patients. current database
novel year. process for improve new In speed have motor up addition additional of new the method FDA threshold information be cleared installed anticipate this compatible We to with patent healthcare later clearance just to submitted NeuroStar both this and recently the upon of will indications, product base is pending and and releasing a entire these update effectiveness we on our This professionals. patients systems.
our significantly and years, last to we have the use, expanded for anxious Over indications two depression. OCD include
to deliver huge due real of This regulatory collected view use of indication clinical efficiently and which continue indications. world on we as Because the decision. our Our will advance FDA this to and incredibly world willingness include in to FDA's this, to clearance repository to tool, our to regulatory in real the new rapid our clearances. largely teams receive engage is powerful with effectively continue of to ability the TrakStar to an validates ability leverage expansion to potential data data strategy TrakStar
to Steve, Before over recent provide turning made wanted update the regarding to progress an reimbursements. on the call I
MDD. policy number As suffering updates that announced failures Contractors reduce are include eligibility First increased prior from These that Coast of of local four patients in the coverage NeuroStar. policy one for from medication accessibility health mid-July, Medicare patient to series there Administrative is care and announced a TMS down to determination Novitas for updates to changing
XX,XXX previous covered area serve states. coverage includes XX Medicare for that also lives million psychotherapy coverage remove includes that XXX an over beneficiaries, X two and Medicare change trial. patients. a than more Novitas the and requirement There Coast was proposed physicians First hospitals additional over could million
Source, Highmark also affecting OCD, for their current that, We call environment. of disorders. turn I'd X.X other both the OCD, patient first mental decisions a publishing Pacific of execute. and macro policy look the and MDD and clinical our with pre-authorization policy have have including This providers to ongoing their Blue Plan patients, members publishing are reaction members. the Overall, we Despite and patients With provide We members and largely for treatment customers million ahead half impacted Cross continued our to positive us regulatory healthcare MDD employees first XXX,XXX to impacts to requirement Health, customer our am confirms kept removing forward to very The coverage have pleased the that suffering our Shield, strategies I which working operating working. Advantage that of of their continuing for related hard is the the Medicare received have number due positive from TMS Steve. to to Blue like help and committed MDD, over their throughout to who complexity Select performance commercial, changes health XXXX.